Total Raised

$127.4M

Investors Count

6

Deal Terms

1

Funding, Valuation & Revenue

3 Fundings

Anumana has raised $127.4M over 3 rounds.

Anumana's latest funding round was a Series C for $95.4M on April 24, 2025.

Anumana's latest post-money valuation is from April 2025.

Sign up for a free demo to see Anumana's valuations in April 2025 and more.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

4/24/2025

Series C

$95.4M

$XXM

0

FY undefined

3

11/17/2022

Unattributed

$XXM

$XXM

0

FY undefined

10

6/7/2022

Incubator/Accelerator

$XXM

0

FY undefined

10

Date

4/24/2025

11/17/2022

6/7/2022

Round

Series C

Unattributed

Incubator/Accelerator

Amount

$95.4M

$XXM

Investors

Valuation

$XXM

$XXM

$XXM

Revenue

0

FY undefined

0

FY undefined

0

FY undefined

Sources

3

10

10

Start free trial
New call-to-action

Anumana Deal Terms

1 Deal Term

Anumana's deal structure is available for 1 funding round, including their Series C from April 24, 2025.

Round

Series C

Funding Date

$XXM

Pre-Money Valuation

$XXM

Post-Money Valuation

$XXM

Amount Raised

$XXM

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

$XXM

Board Voting

$XXM

Par Value

Round

Funding Date

Pre-Money Valuation

Post-Money Valuation

Amount Raised

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

Board Voting

Par Value

Series C

$XXM

$XXM

$XXM

$XXM

$XXM

$XXM

Anumana Investors

6 Investors

Anumana has 6 investors. Mayo Clinic invested in Anumana's Series C funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

4/24/2025

4/24/2025

1
Series C

Non-Profit Foundation

Minnesota

00/00/0000

00/00/0000

NTT Venture Capital

Subscribe to see more

Corporate Venture

California

00/00/0000

00/00/0000

Matrix Capital

Subscribe to see more

Asset/Investment Management

Russian Federation

00/00/0000

00/00/0000

Matrix Partners

Subscribe to see more

Venture Capital

California

00/00/0000

00/00/0000

Boston Scientific

Subscribe to see more

Corporation

Massachusetts

First funding

4/24/2025

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Last Funding

4/24/2025

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Investor

NTT Venture Capital

Matrix Capital

Matrix Partners

Boston Scientific

Rounds

1
Series C

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Board Seats

Type

Non-Profit Foundation

Corporate Venture

Asset/Investment Management

Venture Capital

Corporation

Location

Minnesota

California

Russian Federation

California

Massachusetts

Anumana Acquisitions

1 Acquisition

Anumana acquired 1 company. Their latest acquisition was NeuTrace on November 07, 2022.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

11/7/2022

Convertible Note

$XXM

$9.8M

Acquired

16

Date

11/7/2022

Investment Stage

Convertible Note

Companies

Valuation

$XXM

Total Funding

$9.8M

Note

Acquired

Sources

16

New call-to-action

Compare Anumana to Competitors

Idoven Logo
Idoven

Idoven is a health technology company that focuses on detection and medicine in the cardiovascular domain. The company offers an artificial intelligence (AI)-powered platform that improves the speed, consistency, and accuracy of electrocardiogram (ECG) interpretation and works with existing ECG devices to support clinician decision-making and disease management. It was founded in 2018 and is based in Madrid, Spain.

Powerful Medical Logo
Powerful Medical

Powerful Medical focuses on artificial intelligence (AI) driven healthcare solutions within the medical diagnostics sector. The company provides the PMcardio platform, which uses artificial intelligence to interpret 12-lead electrocardiograms (ECGs) for the diagnosis of cardiovascular diseases. PMcardio's technology aims to assist healthcare professionals by improving diagnostic capabilities and facilitating care coordination. It was founded in 2017 and is based in Bratislava, Slovakia (Slovak Republic).

Cardiomatics Logo
Cardiomatics

Cardiomatics operates in the healthcare technology sector, focusing on ECG analysis. The company provides automated long-term ECG interpretation and arrhythmia diagnostics using a cloud-based platform for ECG signal analysis and reporting. Cardiomatics serves cardiac clinics and service providers. It was founded in 2017 and is based in Krakow, Poland.

Cardiolyse Logo
Cardiolyse

Cardiolyse is a cloud-based platform that provides Electrocardiogram and heart rate variability (HRV) analytics for the healthcare sector. The company offers services including remote heart health monitoring, detection of heart conditions, and predictions of cardiovascular events using machine-learning algorithms. Cardiolyse serves healthcare providers, insurance companies, and individuals at risk for heart disorders. It was founded in 2015 and is based in Helsinki, Finland.

Ultromics Logo
Ultromics

Ultromics operates within the medical technology industry and focuses on heart failure detection. The company offers diagnostic tools that analyze echocardiograms to identify conditions such as heart failure with preserved ejection fraction (HFpEF) and cardiac amyloidosis, providing clinicians with reports to assist in clinical decisions. Ultromics serves healthcare providers, including hospitals and clinics, by integrating its technology into existing medical imaging workflows. It was founded in 2017 and is based in Oxford, England.

A
Abbott Cardiac Rhythm Management

Abbott Cardiac Rhythm Management specializes in the development of medical devices and solutions for treating cardiovascular conditions. The company offers a range of products that assist in cardiac rhythm management, vascular health, and heart failure monitoring, designed to improve patient outcomes and support healthcare professionals. These products are primarily utilized within the healthcare sector, including hospitals, clinics, and by healthcare professionals specializing in cardiovascular care. It was founded in 2018 and is based in Abbott Park, Illinois.

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.